Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences
Accesswire
*LAVAL, QC / ACCESSWIRE / June 14, 2024 / *Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global diversified pharmaceutical..